Seroepidemiological surveillance of SARS-CoV-2 circulation in 41 municipalities in Honduras with no report of active cases, COVID-19, June 16-23, 2020
DOI:
https://doi.org/10.15517/psm.v18i2.43261Keywords:
SARS-CoV-2, Honduras, SerologyAbstract
Introduction: In Honduras on March 12, 2020, the first case of COVID-19 caused by the SARS-CoV-2 was reported. From that moment on, a series of measures were adopted to slow down contact throughout the country. By June 2020, cases are reported across the whole country. With the objective of identifying the presence and circulation of SARS-CoV-2, characterizing and identifying suggestive symptoms of COVID-19 in the population, the present study was carried out. Methodology: A descriptive cross-sectional study was carried out, using a quantitative and qualitative approach, using the LQAS sampling method. The study population was the inhabitants of the identified municipalities, with no current circulation data for SARS-CoV-2 or the municipalities whose last confirmed case was 21 days ago. The data was collected through an electronic survey, it was possible to apply rapid antibody detection tests (IgG and IgM). Results: 792 people from 41 municipalities of the country were surveyed and tested. Positivity of contact was found in 6.2% (49/792). Of these, 55.1% (27/49) are men. 61.2% (30/49) are between 20 and 49 years old. The clinical symptoms found were fever, decreased appetite, respiratory distress, and loss of taste and smell, the 49.2% (32/49) without symptoms. Conclusions: virus circulation was demonstrated in the population of municipalities in which no cases were officially reported and after 96 days of the first confirmed case in the country. Detection of virus-specific antibodies could be important in surveys for asymptomatic infection in areas where contact is expected.
Downloads
References
Decreto Ejecutivo N° PCM-005-2020 (2020). Recuperado de https://www.tsc.gob.hn/web/leyes/Decreto- 33-2020.pdf
Decreto Ejecutivo, N° PCM-021-2020 (2020). Recuperado de https://presidencia.gob.hn/index.php/sala-de-prensa/7016-decreto-ejecutivo-numero-pcm-021-2020
Despacho de Comunicaciones y Estrategia Presidencial. (2020a). Coronavirus COVID-19 En Honduras. Recuperado de https://covid19honduras.org/
Despacho de Comunicaciones y Estrategia Presidencial. (2020b). Recibe el alta la paciente cero, primer caso de COVID-19 en Honduras. Recuperado de https://covid19honduras.org/?q=paciente-cero-recibe-el-alta
Gao, J., Huang, X., Gu, H., Lou, L. y Xu, Z. (2020). Predictive criteria of severe cases in COVID-19 patients of early stage. Research Square, [Preprint]. DOI: https://doi.org/10.21203/rs.3.rs-39161/v1 DOI: https://doi.org/10.21203/rs.3.rs-39161/v1
Guo, Y.-R., Cao, Q.-D., Hong, Z.-S., Tan, Y.-Y., Chen, S.-D., Jin, H.-J. y Yan, Y. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Military Medical Research, 7(1), 11. Doi: https://doi.org/10.1186/s40779-020-00240-0 DOI: https://doi.org/10.1186/s40779-020-00240-0
Hou, H., Wang, T., Zhang, B., Luo, Y., Mao, L., Wang, F. y Sun, Z. (2020). Detection of IgM and IgG antibodies in patients with coronavirus disease 2019. Clinical & Translational Immunology, 9(5), e01136. Doi: https://doi.org/10.1002/cti2.1136 DOI: https://doi.org/10.1002/cti2.1136
John Hopkins Center for Health Security. (2020). Serology-based tests for COVID-19 [Sitio web]. Recuperado de https://www.centerforhealthsecurity.org/resources/COVID-19/serology/Serology-based-tests-for-COVID-19.html
Klein, S. L. y Flanagan, K. L. (2016). Sex differences in immune responses. Nature reviews Immunology, 16(10), 626–638. Doi: https://doi.org/10.1038/nri.2016.90 DOI: https://doi.org/10.1038/nri.2016.90
Organización Mundial de la Salud. (2020). Neumonía de causa desconocida – China: Brotes epidémicos. Recuperado de https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/es/
Ramírez, P. A., Valencia, Y. E., Carrillo, C. Q., Ayala, E. V., Delgado, J. d. L. y Cruz, A. P. (2020). Pruebas diagnósticas para la COVID-19: la importancia del antes y el después. Horizonte MéDico (Lima), 20(2). Recuperado de http://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/1231 DOI: https://doi.org/10.24265/horizmed.2020.v20n2.14
Sethuraman, N., Jeremiah, S. S. y Ryo, A. (2020). Interpreting Diagnostic Tests for SARS-CoV-2. JAMA, 323(22). Doi: https://doi.org/10.1001/jama.2020.8259 DOI: https://doi.org/10.1001/jama.2020.8259
Stringhini, S., Wisniak, A., Piumatti, G., Azman, A. S., Lauer, S. A., Baysson, H. y Guessous, I. (2020). Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. The Lancet, 396(10247), 313-319. Doi: https://doi.org/10.1016/S0140-6736(20)31304-0 DOI: https://doi.org/10.1016/S0140-6736(20)31304-0
Sun, P., Lu, X., Xu, C., Sun, W. y Pan, B. (2020). Understanding of COVID-19 based on current evidence. Journal of medical virology, 92(6), 548–551. Doi: https://doi.org/10.1002/jmv.25722 DOI: https://doi.org/10.1002/jmv.25722
Valadez, J., Weiss, W., Leburg, C. y Davis, R. (2002). LQAS Participant's Manual 2007 - CORE Group. Recuperado de https://www.yumpu.com/en/document/read/22874006/lqas-participants-manual-2007-core-group
World Health Organization. (2020). Coronavirus Disease (COVID-19) Dashboard. Recuperado de https://covid19.who.int/?gclid=Cj0KCQjwvIT5BRCqARIsAAwwD-SYDaVY_b6viVzl43hDLUTB2Kkr0_ZcdeCiJab7ibeCv4sRtfowMkgaAoYSEALw_wcB
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Zhou, Y. (2020). Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International journal of infectious diseases, 94, 91–95. Doi: https://doi.org/10.1016/j.ijid.2020.03.017 DOI: https://doi.org/10.1016/j.ijid.2020.03.017
Yin, Y. y Wunderink, R. (2018). MERS, SARS and other coronaviruses as causes of pneumonia. Respirology, 23(2), 130–137. Doi: https://doi.org/10.1111/resp.13196 DOI: https://doi.org/10.1111/resp.13196
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Mario Rene Mejía Núñez, José Ángel Lara, Sandra Jeanneth Araujo Pleitez, Gilberto Ariel Ramírez
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Population and Health in Mesoamerica informs its authors and readers that all publications must be submitted with the Letter of Acceptance of Copyright Conditions where the authors are asked for authorization to submit the article to the Journal for consideration so that it may carry out any of the following activities:
- The graphic and style editing of the work or part of it.
The publication and reproduction of the work or part of it, both in print and electronic media, including the Internet and any other known or unknown technology.
The translation of the work or part of it into any language or dialect.
The adaptation of the work to reading, sound, voice and any other available technical representation or mechanism, which makes possible its access for partially or totally blind people, or with any other form of special abilities that prevent their access to the conventional reading of the article.
The distribution and availability of the work to the public, in such a way that the public may have access to them from the time and place that each person chooses, through the physical or electronic mechanisms available to them.
Any other form of use, process or system known or to be known that is related to the activities and editorial purposes to which the Journal is linked.
You can access the Letter by clicking HERE. If you have a question, please write to revista.ccp@ucr.ac.cr
In addition, the content of this site is protected under the Attribution - Noncommercial - Share Alike (by-nc-sa) license which permits commercial use of the original work or derivative works and distribution of which must be made under the same license that governs the original work. The graphic design, images and texts generated by the e-Information Science magazine are property of the Universidad de Costa Rica and are licensed under Creative Commons Attribution - NonCommercial - Attribution-ShareAlike 4.0 International.
Authors who publish in this journal accept the following conditions:
-The authors retain their moral rights over the publication and assign the patrimonial rights mentioned in the Letter of Assignment of Rights with the Creative Commons Attribution - NonCommercial - Compatitr Equal 4.0 International license, which allows third parties to use what is published as long as they mention the authorship of the work and to the first publication in this journal.
-Authors may make other independent and additional contractual arrangements for non-exclusive distribution of the version of the article published in this journal (e.g., inclusion in an institutional repository or publication in a book) as long as they clearly indicate that the work was first published in this journal.
This policy is established in accordance with Law 6638 on Copyright and Related Rights of the Republic of Costa Rica.
